首页 > 最新文献

Regulatory Peptides最新文献

英文 中文
A case of esophageal squamous cell carcinoma accompanied by pancreatic and bile duct metastases: Successful treatment starts with an accurate diagnosis. 一例伴有胰腺和胆管转移的食管鳞状细胞癌:成功的治疗始于准确的诊断。
IF 1.3 Pub Date : 2023-10-01 Epub Date: 2022-09-03 DOI: 10.4103/jcrt.jcrt_1891_21
Yuki Ito, Yoshihiro Ikura, Hiroaki Sawai, Tatsuya Osuga

Abstract: Pancreatic and bile duct metastases from esophageal cancer are extremely rare. We report a case of advanced esophageal cancer successfully treated with chemotherapy, selected on the basis of an accurate pathologic diagnosis. A 69-year-old man with chronic renal dysfunction presented with persistent abdominal pain and anorexia. Upper gastrointestinal endoscopy revealed an irregular-shaped tumor in the lower esophagus. Computed tomography and ultrasonography revealed swollen para-aortic lymph nodes, a pancreatic mass, and distal bile duct stenosis. Histopathological examination showed that all of the lesions were squamous cell carcinoma with unique immunohistochemical characteristics of p40+ and cytokeratin 7+. The final diagnosis was esophageal squamous cell carcinoma accompanied by lymph node, pancreas, and bile duct metastases. Taking his renal dysfunction into consideration, modified FOLFOX was administered as the first-line chemotherapy. The patient survived for 15 months since his first presentation. The favorable outcome was attributed to the accurate diagnosis based on comprehensive tissue sampling.

摘要:食管癌的胰腺和胆管转移极为罕见。我们报告了一例在准确病理诊断基础上选择化疗并成功治疗的晚期食管癌病例。一名患有慢性肾功能不全的 69 岁男子出现持续性腹痛和厌食。上消化道内镜检查发现食管下段有一个形状不规则的肿瘤。计算机断层扫描和超声波检查发现主动脉旁淋巴结肿大、胰腺肿块和远端胆管狭窄。组织病理学检查显示,所有病变均为鳞状细胞癌,具有 p40+ 和细胞角蛋白 7+ 的独特免疫组化特征。最终诊断为食管鳞状细胞癌,并伴有淋巴结、胰腺和胆管转移。考虑到他的肾功能不全,改良 FOLFOX 被作为一线化疗方案。患者自首次就诊以来存活了 15 个月。良好的结果归功于基于全面组织取样的准确诊断。
{"title":"A case of esophageal squamous cell carcinoma accompanied by pancreatic and bile duct metastases: Successful treatment starts with an accurate diagnosis.","authors":"Yuki Ito, Yoshihiro Ikura, Hiroaki Sawai, Tatsuya Osuga","doi":"10.4103/jcrt.jcrt_1891_21","DOIUrl":"10.4103/jcrt.jcrt_1891_21","url":null,"abstract":"<p><strong>Abstract: </strong>Pancreatic and bile duct metastases from esophageal cancer are extremely rare. We report a case of advanced esophageal cancer successfully treated with chemotherapy, selected on the basis of an accurate pathologic diagnosis. A 69-year-old man with chronic renal dysfunction presented with persistent abdominal pain and anorexia. Upper gastrointestinal endoscopy revealed an irregular-shaped tumor in the lower esophagus. Computed tomography and ultrasonography revealed swollen para-aortic lymph nodes, a pancreatic mass, and distal bile duct stenosis. Histopathological examination showed that all of the lesions were squamous cell carcinoma with unique immunohistochemical characteristics of p40+ and cytokeratin 7+. The final diagnosis was esophageal squamous cell carcinoma accompanied by lymph node, pancreas, and bile duct metastases. Taking his renal dysfunction into consideration, modified FOLFOX was administered as the first-line chemotherapy. The patient survived for 15 months since his first presentation. The favorable outcome was attributed to the accurate diagnosis based on comprehensive tissue sampling.</p>","PeriodicalId":20853,"journal":{"name":"Regulatory Peptides","volume":"64 1","pages":"2060-2063"},"PeriodicalIF":1.3,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75212553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does acupuncture therapy improve language function of patients with aphasia following ischemic stroke? A systematic review and meta-analysis. 针灸疗法能改善缺血性中风失语患者的语言功能吗?系统回顾与荟萃分析。
IF 1.7 Pub Date : 2022-01-01 DOI: 10.3233/NRE-220007
Bomo Sang, Shizhe Deng, Jingbo Zhai, Ting Hao, Bifang Zhuo, Chenyang Qin, Menglong Zhang, Xiaofeng Zhao, Zhihong Meng

Background: Aphasia is one of the most common complications in patients with ischemic stroke. Studies have shown that acupuncture can improve the symptoms of aphasia patients. However, the effect of acupuncture on language function in patients with ischemic stroke is still controversial.

Objective: This study aimed to critically assess the efficacy and safety of acupuncture for aphasia following ischemic stroke.

Methods: PubMed, Embase, Cochrane Central Register of Controlled Trials, Web of Science Core Collection, China National Knowledge Infrastructure, Wanfang Digital Periodicals, and Chinese Science and Technology Periodicals database were searched. All randomized controlled trials (RCTs) that met the criteria were included.

Results: Meta-analyses showed that mean difference in change of auditory comprehension score (MD = 7.71, 95% CI: 1.83 to 13.59, P = 0.01), spontaneous speech (MD = 2.77, 95% CI: 0.59 to 4.95, P = 0.01), repetition score (MD = 14.48, 95% CI: 11.04 to 17.91, P < 0.00001) and naming score (MD = 14.60, 95% CI: 11.33 to 17.88, P < 0.00001) measured by WAB scale were statistically significant. Subgroup analyses demonstrated that there were statistically significant mean differences in four items of WAB scale in patients with sub-acute stroke, and no statistically significant differences in patients with acute stroke.

Conclusion: The present study suggests that acupuncture may improve the language function of patients with aphasia following ischemic stroke, especially during the sub-acute phase. However, due to insufficient sample sizes and information on the safety, more high-quality RCTs are still needed.

背景:失语症是缺血性脑卒中患者最常见的并发症之一:失语症是缺血性中风患者最常见的并发症之一。研究表明,针灸可以改善失语症患者的症状。然而,针灸对缺血性中风患者语言功能的影响仍存在争议:本研究旨在严格评估针灸治疗缺血性中风失语症的有效性和安全性:方法:检索了 PubMed、Embase、Cochrane Central Register of Controlled Trials、Web of Science Core Collection、China National Knowledge Infrastructure、万方数据期刊网和中国科技期刊数据库。所有符合标准的随机对照试验(RCT)均被纳入:Meta分析表明,听觉理解力评分(MD=7.71,95% CI:1.83~13.59,P=0.01)、自发言语(MD=2.77,95% CI:0.59~4.95,P=0.01)、复述评分(MD=14.48,95% CI:11.04~17.91,P 结论:本研究表明,针灸可改善听觉理解力评分、自发言语、复述评分、听力理解力评分和听力理解力评分的变化:本研究表明,针灸可改善缺血性脑卒中失语患者的语言功能,尤其是在亚急性期。然而,由于样本量和安全性方面的信息不足,仍需要更多高质量的 RCT 研究。
{"title":"Does acupuncture therapy improve language function of patients with aphasia following ischemic stroke? A systematic review and meta-analysis.","authors":"Bomo Sang, Shizhe Deng, Jingbo Zhai, Ting Hao, Bifang Zhuo, Chenyang Qin, Menglong Zhang, Xiaofeng Zhao, Zhihong Meng","doi":"10.3233/NRE-220007","DOIUrl":"10.3233/NRE-220007","url":null,"abstract":"<p><strong>Background: </strong>Aphasia is one of the most common complications in patients with ischemic stroke. Studies have shown that acupuncture can improve the symptoms of aphasia patients. However, the effect of acupuncture on language function in patients with ischemic stroke is still controversial.</p><p><strong>Objective: </strong>This study aimed to critically assess the efficacy and safety of acupuncture for aphasia following ischemic stroke.</p><p><strong>Methods: </strong>PubMed, Embase, Cochrane Central Register of Controlled Trials, Web of Science Core Collection, China National Knowledge Infrastructure, Wanfang Digital Periodicals, and Chinese Science and Technology Periodicals database were searched. All randomized controlled trials (RCTs) that met the criteria were included.</p><p><strong>Results: </strong>Meta-analyses showed that mean difference in change of auditory comprehension score (MD = 7.71, 95% CI: 1.83 to 13.59, P = 0.01), spontaneous speech (MD = 2.77, 95% CI: 0.59 to 4.95, P = 0.01), repetition score (MD = 14.48, 95% CI: 11.04 to 17.91, P < 0.00001) and naming score (MD = 14.60, 95% CI: 11.33 to 17.88, P < 0.00001) measured by WAB scale were statistically significant. Subgroup analyses demonstrated that there were statistically significant mean differences in four items of WAB scale in patients with sub-acute stroke, and no statistically significant differences in patients with acute stroke.</p><p><strong>Conclusion: </strong>The present study suggests that acupuncture may improve the language function of patients with aphasia following ischemic stroke, especially during the sub-acute phase. However, due to insufficient sample sizes and information on the safety, more high-quality RCTs are still needed.</p>","PeriodicalId":20853,"journal":{"name":"Regulatory Peptides","volume":"101 1","pages":"231-245"},"PeriodicalIF":1.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535561/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78118948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Usefulness of a deep learning system for diagnosing Sjögren's syndrome using ultrasonography images. 利用超声图像诊断Sjögren综合征的深度学习系统的实用性。
IF 3.3 Pub Date : 2020-03-01 Epub Date: 2019-12-11 DOI: 10.1259/dmfr.20190348
Yoshitaka Kise, Mayumi Shimizu, Haruka Ikeda, Takeshi Fujii, Chiaki Kuwada, Masako Nishiyama, Takuma Funakoshi, Yoshiko Ariji, Hiroshi Fujita, Akitoshi Katsumata, Kazunori Yoshiura, Eiichiro Ariji

Objectives: We evaluated the diagnostic performance of a deep learning system for the detection of Sjögren's syndrome (SjS) in ultrasonography (US) images, and compared it with the performance of inexperienced radiologists.

Methods: 100 patients with a confirmed diagnosis of SjS according to both the Japanese criteria and American-European Consensus Group criteria and 100 non-SjS patients that had a dry mouth and suspected SjS but were definitively diagnosed as non-SjS were enrolled in this study. All the patients underwent US scans of both the parotid glands (PG) and submandibular glands (SMG). The training group consisted of 80 SjS patients and 80 non-SjS patients, whereas the test group consisted of 20 SjS patients and 20 non-SjS patients for deep learning analysis. The performance of the deep learning system for diagnosing SjS from the US images was compared with the diagnoses made by three inexperienced radiologists.

Results: The accuracy, sensitivity and specificity of the deep learning system for the PG were 89.5, 90.0 and 89.0%, respectively, and those for the inexperienced radiologists were 76.7, 67.0 and 86.3%, respectively. The deep learning system results for the SMG were 84.0, 81.0 and 87.0%, respectively, and those for the inexperienced radiologists were 72.0, 78.0 and 66.0%, respectively. The AUC for the inexperienced radiologists was significantly different from that of the deep learning system.

Conclusions: The deep learning system had a high diagnostic ability for SjS. This suggests that deep learning could be used for diagnostic support when interpreting US images.

目的:我们评估了深度学习系统在超声(US)图像中检测Sjögren综合征(SjS)的诊断性能,并将其与经验不足的放射科医生的表现进行了比较。方法:入选100例根据日本标准和欧美共识组标准确诊为SjS的患者,以及100例有口干和疑似SjS但明确诊断为非SjS的非SjS患者。所有患者都接受了腮腺(PG)和下颌下腺(SMG)的超声扫描。训练组由80名SjS患者和80名非SjS患者组成,试验组由20名SjS患者和20名非SjS患者组成,进行深度学习分析。将深度学习系统从美国图像中诊断SjS的性能与三位没有经验的放射科医生的诊断进行比较。结果:深度学习系统对PG的准确率、灵敏度和特异性分别为89.5%、90.0和89.0%,对无经验放射科医师的准确率分别为76.7、67.0和86.3%。SMG的深度学习系统结果分别为84.0、81.0和87.0%,经验不足的放射科医生的深度学习系统结果分别为72.0、78.0和66.0%。经验不足的放射科医生的AUC与深度学习系统的AUC有显著差异。结论:深度学习系统对SjS具有较高的诊断能力。这表明深度学习可以在解释美国图像时用于诊断支持。
{"title":"Usefulness of a deep learning system for diagnosing Sjögren's syndrome using ultrasonography images.","authors":"Yoshitaka Kise, Mayumi Shimizu, Haruka Ikeda, Takeshi Fujii, Chiaki Kuwada, Masako Nishiyama, Takuma Funakoshi, Yoshiko Ariji, Hiroshi Fujita, Akitoshi Katsumata, Kazunori Yoshiura, Eiichiro Ariji","doi":"10.1259/dmfr.20190348","DOIUrl":"10.1259/dmfr.20190348","url":null,"abstract":"<p><strong>Objectives: </strong>We evaluated the diagnostic performance of a deep learning system for the detection of Sjögren's syndrome (SjS) in ultrasonography (US) images, and compared it with the performance of inexperienced radiologists.</p><p><strong>Methods: </strong>100 patients with a confirmed diagnosis of SjS according to both the Japanese criteria and American-European Consensus Group criteria and 100 non-SjS patients that had a dry mouth and suspected SjS but were definitively diagnosed as non-SjS were enrolled in this study. All the patients underwent US scans of both the parotid glands (PG) and submandibular glands (SMG). The training group consisted of 80 SjS patients and 80 non-SjS patients, whereas the test group consisted of 20 SjS patients and 20 non-SjS patients for deep learning analysis. The performance of the deep learning system for diagnosing SjS from the US images was compared with the diagnoses made by three inexperienced radiologists.</p><p><strong>Results: </strong>The accuracy, sensitivity and specificity of the deep learning system for the PG were 89.5, 90.0 and 89.0%, respectively, and those for the inexperienced radiologists were 76.7, 67.0 and 86.3%, respectively. The deep learning system results for the SMG were 84.0, 81.0 and 87.0%, respectively, and those for the inexperienced radiologists were 72.0, 78.0 and 66.0%, respectively. The AUC for the inexperienced radiologists was significantly different from that of the deep learning system.</p><p><strong>Conclusions: </strong>The deep learning system had a high diagnostic ability for SjS. This suggests that deep learning could be used for diagnostic support when interpreting US images.</p>","PeriodicalId":20853,"journal":{"name":"Regulatory Peptides","volume":"40 1","pages":"20190348"},"PeriodicalIF":3.3,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1259/dmfr.20190348","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75130123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 24
Patterns and Determinants of Prescribing for Parkinson's Disease: A Systematic Literature Review. 帕金森病处方的模式和决定因素:系统性文献综述。
IF 6.7 Pub Date : 2019-11-03 eCollection Date: 2019-01-01 DOI: 10.1155/2019/9237181
Khalid Orayj, Emma Lane

Since the discovery of levodopa (L-dopa) in 1967, the range of medications available to treat Parkinson's disease has increased significantly and guidance on the use, efficacy, and safety of these medications has evolved. To assess levels of adherence to national prescribing guidelines and awareness of changes in the efficacy and safety data published in the profiles of medications for the treatment of PD, we have reviewed studies on patterns and determinants of prescribing PD medications conducted in the last 50 years (since the discovery of L-dopa). A systematic literature review was conducted using EMBASE (1967 to March, 2018), Ovid MEDLINE(R) ALL (1967 to March 16, 2018), PsycINFO (1967 to the 2nd week of March, 2018), and PubMed to identify all studies measuring prescribing patterns of PD medication between 1967 and 2017. Study design, source of data, country, year of study, number of patients and/or prescriptions, unit of analysis, prescribing determinants, and percentage utilisation of PD medications were extracted where possible. 44 studies examining prescribing patterns and/or prescribing determinants across 17 countries were identified. Unsurprisingly, L-dopa was the most commonly prescribed medication in all studies, accounting for 46.50% to 100% of all prescriptions for PD. In several studies, the prescribing rate of ergot-derived dopamine agonists (DAs) decreased over time in concordance with guidance. In contrast, the prescribing rates of non-ergot DAs increased over the last ten years in most of the included studies. In examining prescribing factors, two major categories were exemplified, patients' factors and prescribers' factors, with patients' age being the most common factor that affected the prescription in most studies. In conclusion, L-dopa is now the most commonly prescribed medication for cases of PD but there is large variation in the prescribing rates of catechol-O-methyltransferase (COMT) inhibitors, monoamine oxidase B (MAO-B) inhibitors, amantadine, and anticholinergics between countries. New studies examining the effects of recent clinical trials and measuring the prescribing rates of newly approved medications are warranted.

自 1967 年发现左旋多巴(L-多巴)以来,可用于治疗帕金森病的药物种类大幅增加,有关这些药物的使用、疗效和安全性的指导也在不断发展。为了评估对国家处方指南的遵守程度以及对帕金森病治疗药物简介中公布的疗效和安全性数据变化的了解程度,我们回顾了过去 50 年(自发现左旋多巴以来)进行的有关帕金森病药物处方模式和决定因素的研究。我们使用 EMBASE(1967 年至 2018 年 3 月)、Ovid MEDLINE(R) ALL(1967 年至 2018 年 3 月 16 日)、PsycINFO(1967 年至 2018 年 3 月第二周)和 PubMed 进行了系统性文献综述,以确定 1967 年至 2017 年期间所有衡量 PD 药物处方模式的研究。在可能的情况下,提取了研究设计、数据来源、国家、研究年份、患者和/或处方数量、分析单位、处方决定因素以及PD药物使用百分比。共发现了 44 项研究,对 17 个国家的处方模式和/或处方决定因素进行了研究。毫不奇怪,在所有研究中,左旋多巴是最常用的处方药,占所有帕金森病处方药的 46.50%至 100%。在多项研究中,麦角衍生的多巴胺受体激动剂(DAs)的处方率随着时间的推移而下降,与指导意见一致。相比之下,在大多数纳入的研究中,非麦角类多巴胺受体激动剂的处方率在过去十年中有所上升。在研究处方因素时,主要分为两类:患者因素和处方者因素,其中患者年龄是大多数研究中影响处方的最常见因素。总之,左旋多巴是目前治疗帕金森病最常用的处方药,但儿茶酚-O-甲基转移酶(COMT)抑制剂、单胺氧化酶 B(MAO-B)抑制剂、金刚烷胺和抗胆碱能药物的处方率在各国之间存在很大差异。有必要开展新的研究,检查近期临床试验的效果并衡量新批准药物的处方率。
{"title":"Patterns and Determinants of Prescribing for Parkinson's Disease: A Systematic Literature Review.","authors":"Khalid Orayj, Emma Lane","doi":"10.1155/2019/9237181","DOIUrl":"10.1155/2019/9237181","url":null,"abstract":"<p><p>Since the discovery of levodopa (L-dopa) in 1967, the range of medications available to treat Parkinson's disease has increased significantly and guidance on the use, efficacy, and safety of these medications has evolved. To assess levels of adherence to national prescribing guidelines and awareness of changes in the efficacy and safety data published in the profiles of medications for the treatment of PD, we have reviewed studies on patterns and determinants of prescribing PD medications conducted in the last 50 years (since the discovery of L-dopa). A systematic literature review was conducted using EMBASE (1967 to March, 2018), Ovid MEDLINE(R) ALL (1967 to March 16, 2018), PsycINFO (1967 to the 2<sup>nd</sup> week of March, 2018), and PubMed to identify all studies measuring prescribing patterns of PD medication between 1967 and 2017. Study design, source of data, country, year of study, number of patients and/or prescriptions, unit of analysis, prescribing determinants, and percentage utilisation of PD medications were extracted where possible. 44 studies examining prescribing patterns and/or prescribing determinants across 17 countries were identified. Unsurprisingly, L-dopa was the most commonly prescribed medication in all studies, accounting for 46.50% to 100% of all prescriptions for PD. In several studies, the prescribing rate of ergot-derived dopamine agonists (DAs) decreased over time in concordance with guidance. In contrast, the prescribing rates of non-ergot DAs increased over the last ten years in most of the included studies. In examining prescribing factors, two major categories were exemplified, patients' factors and prescribers' factors, with patients' age being the most common factor that affected the prescription in most studies. In conclusion, L-dopa is now the most commonly prescribed medication for cases of PD but there is large variation in the prescribing rates of catechol-O-methyltransferase (COMT) inhibitors, monoamine oxidase B (MAO-B) inhibitors, amantadine, and anticholinergics between countries. New studies examining the effects of recent clinical trials and measuring the prescribing rates of newly approved medications are warranted.</p>","PeriodicalId":20853,"journal":{"name":"Regulatory Peptides","volume":"37 1","pages":"9237181"},"PeriodicalIF":6.7,"publicationDate":"2019-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875178/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75159795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complete Posterior Vitreous Detachment Reduces the Need for Treatment of Diabetic Macular Edema. 完全玻璃体后脱离可减少糖尿病黄斑水肿的治疗需求。
IF 0.9 Pub Date : 2019-11-01 DOI: 10.3928/23258160-20191031-13
William Anderson, Kisha Piggott, Yicheng K Bao, Hang Pham, Sweta Kavali, Rithwick Rajagopal

Background and objective: To evaluate the vitreomacular interface and its relation to treatment burden for diabetic macular edema (DME) in patients without overt vitreomacular traction (VMT).

Patients and methods: A retrospective cohort study of 494 eyes from 274 patients who had macular spectral-domain optical coherence tomography (SD-OCT) and did not have proliferative diabetic retinopathy, DME, or VMT at the initial visit. Posterior vitreous detachment (PVD) was categorized at the initial visit into five stages (0-4) using SD-OCT parameters alone.

Results: Two of 34 eyes (6.9%) presenting with a complete PVD required DME treatment during follow-up, whereas 144 of 460 eyes (31.3%) without a complete PVD at baseline required treatment (P = .001, Chi-squared). After adjusting for age, ethnicity, gender, and HbA1c, complete PVD at baseline was associated with a significant reduction in risk of DME therapy (hazard ratio: 0.18; 95% confidence interval, 0.05-0.73; P = .02).

Conclusion: Complete PVD is independently associated with a reduced need for DME treatment. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:e266-e273.].

背景和目的评估无明显玻璃体白膜牵引(VMT)的糖尿病黄斑水肿(DME)患者的玻璃体白膜界面及其与治疗负担的关系:对274名患者的494只眼睛进行回顾性队列研究,这些患者在初诊时接受了黄斑光谱域光学相干断层扫描(SD-OCT)检查,且没有增殖性糖尿病视网膜病变、DME或VMT。初次就诊时,仅使用 SD-OCT 参数将后玻璃体脱落(PVD)分为五个阶段(0-4):结果:34 只出现完全玻璃体脱落的眼睛中有 2 只(6.9%)需要在随访期间接受 DME 治疗,而基线时未出现完全玻璃体脱落的 460 只眼睛中有 144 只(31.3%)需要接受治疗(P = .001,Chi-squared)。调整年龄、种族、性别和 HbA1c 后,基线时完全 PVD 与 DME 治疗风险的显著降低相关(危险比:0.18;95% 置信区间:0.05-0.73;P = .02):结论:完全的 PVD 与减少 DME 治疗需求有独立联系。[Ophthalmic Surg Lasers Imaging Retina.]
{"title":"Complete Posterior Vitreous Detachment Reduces the Need for Treatment of Diabetic Macular Edema.","authors":"William Anderson, Kisha Piggott, Yicheng K Bao, Hang Pham, Sweta Kavali, Rithwick Rajagopal","doi":"10.3928/23258160-20191031-13","DOIUrl":"10.3928/23258160-20191031-13","url":null,"abstract":"<p><strong>Background and objective: </strong>To evaluate the vitreomacular interface and its relation to treatment burden for diabetic macular edema (DME) in patients without overt vitreomacular traction (VMT).</p><p><strong>Patients and methods: </strong>A retrospective cohort study of 494 eyes from 274 patients who had macular spectral-domain optical coherence tomography (SD-OCT) and did not have proliferative diabetic retinopathy, DME, or VMT at the initial visit. Posterior vitreous detachment (PVD) was categorized at the initial visit into five stages (0-4) using SD-OCT parameters alone.</p><p><strong>Results: </strong>Two of 34 eyes (6.9%) presenting with a complete PVD required DME treatment during follow-up, whereas 144 of 460 eyes (31.3%) without a complete PVD at baseline required treatment (P = .001, Chi-squared). After adjusting for age, ethnicity, gender, and HbA1c, complete PVD at baseline was associated with a significant reduction in risk of DME therapy (hazard ratio: 0.18; 95% confidence interval, 0.05-0.73; P = .02).</p><p><strong>Conclusion: </strong>Complete PVD is independently associated with a reduced need for DME treatment. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:e266-e273.].</p>","PeriodicalId":20853,"journal":{"name":"Regulatory Peptides","volume":"177 1","pages":"e266-e273"},"PeriodicalIF":0.9,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941753/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77312761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tai Chi for rheumatoid arthritis. 太极拳治疗类风湿性关节炎。
IF 8.8 Pub Date : 2019-09-25 DOI: 10.1002/14651858.CD004849.pub2
Amy S Mudano, Peter Tugwell, George A Wells, Jasvinder A Singh
<p><strong>Background: </strong>Rheumatoid arthritis (RA) is a chronic, systemic, inflammatory, autoimmune disease that results in joint deformity and immobility of the musculoskeletal system. The major goals of treatment are to relieve pain, reduce inflammation, slow down or stop joint damage, prevent disability, and preserve or improve the person's sense of well-being and ability to function. Tai Chi, interchangeably known as Tai Chi Chuan, is an ancient Chinese health-promoting martial art form that has been recognized in China as an effective arthritis therapy for centuries. This is an update of a review published in 2004.</p><p><strong>Objectives: </strong>To assess the benefits and harms of Tai Chi as a treatment for people with rheumatoid arthritis (RA).</p><p><strong>Search methods: </strong>We updated the search of CENTRAL, MEDLINE, Embase, and clinical trial registries from 2002 to September 2018.</p><p><strong>Selection criteria: </strong>We selected randomized controlled trials and controlled clinical trials examining the benefits (ACR improvement criteria or pain, disease progression, function, and radiographic progression), and harms (adverse events and withdrawals) of exercise programs with Tai Chi instruction or incorporating principles of Tai Chi philosophy. We included studies of any duration that included control groups who received either no therapy or alternate therapy.</p><p><strong>Data collection and analysis: </strong>We used standard methodological procedures expected by Cochrane.</p><p><strong>Main results: </strong>Adding three studies (156 additional participants) to the original review, this update contains a total of seven trials with 345 participants. Participants were mostly women with RA, ranging in age from 16 to 80 years, who were treated in outpatient settings in China, South Korea, and the USA. The majority of the trials were at high risk of bias for performance and detection bias, due to the lack of blinding of participants or assessors. Almost 75% of the studies did not report random sequence generation, and we judged the risk of bias as unclear for allocation concealment in the majority of studies. The duration of the Tai Chi programs ranged from 8 to 12 weeks.It is uncertain whether Tai Chi-based exercise programs provide a clinically important improvement in pain among Tai Chi participants compared to no therapy or alternate therapy. The change in mean pain in control groups, measured on visual analog scale (VAS 0 to 10 score, reduced score means less pain) ranged from a decrease of 0.51 to an increase of 1.6 at 12 weeks; in the Tai Chi groups, pain was reduced by a mean difference (MD) of -2.15 (95% confidence interval (CI) -3.19 to -1.11); 22% absolute improvement (95% CI, 11% to 32% improvement); 2 studies, 81 participants; very low-quality evidence, downgraded for imprecision, blinding and attrition bias.There was very low-quality evidence, downgraded for, blinding, and attrition, that was inconclusi
这篇更新的综述对先前综述的结论提供了最小的变化,即疼痛结果。 此次更新的审查对上一次审查的结论(即疼痛结果)变化极小。
{"title":"Tai Chi for rheumatoid arthritis.","authors":"Amy S Mudano, Peter Tugwell, George A Wells, Jasvinder A Singh","doi":"10.1002/14651858.CD004849.pub2","DOIUrl":"10.1002/14651858.CD004849.pub2","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Rheumatoid arthritis (RA) is a chronic, systemic, inflammatory, autoimmune disease that results in joint deformity and immobility of the musculoskeletal system. The major goals of treatment are to relieve pain, reduce inflammation, slow down or stop joint damage, prevent disability, and preserve or improve the person's sense of well-being and ability to function. Tai Chi, interchangeably known as Tai Chi Chuan, is an ancient Chinese health-promoting martial art form that has been recognized in China as an effective arthritis therapy for centuries. This is an update of a review published in 2004.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;To assess the benefits and harms of Tai Chi as a treatment for people with rheumatoid arthritis (RA).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Search methods: &lt;/strong&gt;We updated the search of CENTRAL, MEDLINE, Embase, and clinical trial registries from 2002 to September 2018.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Selection criteria: &lt;/strong&gt;We selected randomized controlled trials and controlled clinical trials examining the benefits (ACR improvement criteria or pain, disease progression, function, and radiographic progression), and harms (adverse events and withdrawals) of exercise programs with Tai Chi instruction or incorporating principles of Tai Chi philosophy. We included studies of any duration that included control groups who received either no therapy or alternate therapy.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Data collection and analysis: &lt;/strong&gt;We used standard methodological procedures expected by Cochrane.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main results: &lt;/strong&gt;Adding three studies (156 additional participants) to the original review, this update contains a total of seven trials with 345 participants. Participants were mostly women with RA, ranging in age from 16 to 80 years, who were treated in outpatient settings in China, South Korea, and the USA. The majority of the trials were at high risk of bias for performance and detection bias, due to the lack of blinding of participants or assessors. Almost 75% of the studies did not report random sequence generation, and we judged the risk of bias as unclear for allocation concealment in the majority of studies. The duration of the Tai Chi programs ranged from 8 to 12 weeks.It is uncertain whether Tai Chi-based exercise programs provide a clinically important improvement in pain among Tai Chi participants compared to no therapy or alternate therapy. The change in mean pain in control groups, measured on visual analog scale (VAS 0 to 10 score, reduced score means less pain) ranged from a decrease of 0.51 to an increase of 1.6 at 12 weeks; in the Tai Chi groups, pain was reduced by a mean difference (MD) of -2.15 (95% confidence interval (CI) -3.19 to -1.11); 22% absolute improvement (95% CI, 11% to 32% improvement); 2 studies, 81 participants; very low-quality evidence, downgraded for imprecision, blinding and attrition bias.There was very low-quality evidence, downgraded for, blinding, and attrition, that was inconclusi","PeriodicalId":20853,"journal":{"name":"Regulatory Peptides","volume":"1 1","pages":"CD004849"},"PeriodicalIF":8.8,"publicationDate":"2019-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759565/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75604586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cell mechanics: a dialogue. 细胞力学:对话。
IF 18.1 Pub Date : 2017-03-01 Epub Date: 2017-01-27 DOI: 10.1088/1361-6633/aa5282
Jiaxiang Tao, Yizeng Li, Dhruv K Vig, Sean X Sun

Under the microscope, eukaryotic animal cells can adopt a variety of different shapes and sizes. These cells also move and deform, and the physical mechanisms driving these movements and shape changes are important in fundamental cell biology, tissue mechanics, as well as disease biology. This article reviews some of the basic mechanical concepts in cells, emphasizing continuum mechanics description of cytoskeletal networks and hydrodynamic flows across the cell membrane. We discuss how cells can generate movement and shape changes by controlling mass fluxes at the cell boundary. These mass fluxes can come from polymerization/depolymerization of actin cytoskeleton, as well as osmotic and hydraulic pressure-driven flow of water across the cell membrane. By combining hydraulic pressure control with force balance conditions at the cell surface, we discuss a quantitative mechanism of cell shape and volume control. The broad consequences of this model on cell mechanosensation and tissue mechanics are outlined.

在显微镜下,真核动物细胞可以呈现出各种不同的形状和大小。这些细胞也会移动和变形,而驱动这些移动和形状变化的物理机制在基础细胞生物学、组织力学以及疾病生物学中非常重要。本文回顾了细胞中的一些基本力学概念,强调细胞骨架网络的连续介质力学描述和细胞膜上的流体力学流动。我们讨论了细胞如何通过控制细胞边界的质量流来产生运动和形状变化。这些质量通量可能来自肌动蛋白细胞骨架的聚合/解聚,以及渗透压和水压驱动的细胞膜上的水流。通过将水压控制与细胞表面的力平衡条件相结合,我们讨论了细胞形状和体积控制的定量机制。概述了这一模型对细胞机械感觉和组织力学的广泛影响。
{"title":"Cell mechanics: a dialogue.","authors":"Jiaxiang Tao, Yizeng Li, Dhruv K Vig, Sean X Sun","doi":"10.1088/1361-6633/aa5282","DOIUrl":"10.1088/1361-6633/aa5282","url":null,"abstract":"<p><p>Under the microscope, eukaryotic animal cells can adopt a variety of different shapes and sizes. These cells also move and deform, and the physical mechanisms driving these movements and shape changes are important in fundamental cell biology, tissue mechanics, as well as disease biology. This article reviews some of the basic mechanical concepts in cells, emphasizing continuum mechanics description of cytoskeletal networks and hydrodynamic flows across the cell membrane. We discuss how cells can generate movement and shape changes by controlling mass fluxes at the cell boundary. These mass fluxes can come from polymerization/depolymerization of actin cytoskeleton, as well as osmotic and hydraulic pressure-driven flow of water across the cell membrane. By combining hydraulic pressure control with force balance conditions at the cell surface, we discuss a quantitative mechanism of cell shape and volume control. The broad consequences of this model on cell mechanosensation and tissue mechanics are outlined.</p>","PeriodicalId":20853,"journal":{"name":"Regulatory Peptides","volume":"22 1","pages":"036601"},"PeriodicalIF":18.1,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518794/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75092971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Green and Low-cost Production of Thermally Stable and Carboxylated Cellulose Nanocrystals and Nanofibrils Using Highly Recyclable Dicarboxylic Acids. 利用高度可回收的二羧酸,绿色低成本地生产热稳定的羧化纤维素纳米晶体和纳米纤维。
IF 1.2 Pub Date : 2017-01-09 DOI: 10.3791/55079
Huiyang Bian, Liheng Chen, Ruibin Wang, Junyong Zhu

Here we demonstrate potentially low cost and green productions of high thermally stable and carboxylated cellulose nanocrystals (CNCs) and nanofibrils (CNF) from bleached eucalyptus pulp (BEP) and unbleached mixed hardwood kraft pulp (UMHP) fibers using highly recyclable dicarboxylic solid acids. Typical operating conditions were acid concentrations of 50 - 70 wt% at 100 °C for 60 min and 120 °C (no boiling at atmospheric pressure) for 120 min, for BEP and UMHP, respectively. The resultant CNCs have a higher thermal degradation temperature than their corresponding feed fibers and carboxylic acid group content from 0.2 - 0.4 mmol/g. The low strength (high pKa of 1.0 - 3.0) of organic acids also resulted in CNCs with both longer lengths of approximately 239 - 336 nm and higher crystallinity than CNCs produced using mineral acids. Cellulose loss to sugar was minimal. Fibrous cellulosic solid residue (FCSR) from the dicarboxylic acid hydrolysis was used to produce carboxylated CNFs through subsequent mechanical fibrillation with low energy input.

在此,我们展示了利用高度可回收的二羧酸固体酸从漂白桉木浆(BEP)和未漂白混合硬木牛皮浆(UMHP)纤维中生产高热稳定和羧基化纤维素纳米晶体(CNCs)和纳米纤维(CNF)的低成本绿色方法。对于 BEP 和 UMHP,典型的操作条件是酸浓度为 50 - 70 wt%,温度分别为 100 °C 60 分钟和 120 °C 120 分钟(常压下不沸腾)。生成的 CNC 的热降解温度高于相应的纤维,羧酸基含量为 0.2 - 0.4 mmol/g。有机酸的强度低(pKa 值高达 1.0 - 3.0),因此与使用矿物酸生产的 CNC 相比,CNC 的长度更长(约 239 - 336 nm),结晶度更高。纤维素转化为糖的损失极小。二羧酸水解产生的纤维素固体残渣(FCSR)可用于生产羧化 CNF,随后通过低能量输入的机械纤化进行生产。
{"title":"Green and Low-cost Production of Thermally Stable and Carboxylated Cellulose Nanocrystals and Nanofibrils Using Highly Recyclable Dicarboxylic Acids.","authors":"Huiyang Bian, Liheng Chen, Ruibin Wang, Junyong Zhu","doi":"10.3791/55079","DOIUrl":"10.3791/55079","url":null,"abstract":"<p><p>Here we demonstrate potentially low cost and green productions of high thermally stable and carboxylated cellulose nanocrystals (CNCs) and nanofibrils (CNF) from bleached eucalyptus pulp (BEP) and unbleached mixed hardwood kraft pulp (UMHP) fibers using highly recyclable dicarboxylic solid acids. Typical operating conditions were acid concentrations of 50 - 70 wt% at 100 °C for 60 min and 120 °C (no boiling at atmospheric pressure) for 120 min, for BEP and UMHP, respectively. The resultant CNCs have a higher thermal degradation temperature than their corresponding feed fibers and carboxylic acid group content from 0.2 - 0.4 mmol/g. The low strength (high pKa of 1.0 - 3.0) of organic acids also resulted in CNCs with both longer lengths of approximately 239 - 336 nm and higher crystallinity than CNCs produced using mineral acids. Cellulose loss to sugar was minimal. Fibrous cellulosic solid residue (FCSR) from the dicarboxylic acid hydrolysis was used to produce carboxylated CNFs through subsequent mechanical fibrillation with low energy input.</p>","PeriodicalId":20853,"journal":{"name":"Regulatory Peptides","volume":"37 1","pages":""},"PeriodicalIF":1.2,"publicationDate":"2017-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408715/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75155795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
WITHDRAWN: Effects of centrally-injected glucagon-like peptide-2 on gastric mucosal blood flow in rats; possible mechanisms. 撤回:集中注射胰高血糖素样肽-2对大鼠胃黏膜血流的影响;可能的机制。
Pub Date : 2014-12-06 DOI: 10.1016/j.regpep.2014.12.001
Guldal Gulec-Suyen, Naciye Isbil-Buyukcoskun, Betul Cam, Kasim Ozluk

This article has been withdrawn at the request of the Publisher. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

应出版商的要求,本文已被撤下。出版商对此造成的不便深表歉意。有关爱思唯尔撤稿政策的全文,请访问 http://www.elsevier.com/locate/withdrawalpolicy。
{"title":"WITHDRAWN: Effects of centrally-injected glucagon-like peptide-2 on gastric mucosal blood flow in rats; possible mechanisms.","authors":"Guldal Gulec-Suyen, Naciye Isbil-Buyukcoskun, Betul Cam, Kasim Ozluk","doi":"10.1016/j.regpep.2014.12.001","DOIUrl":"10.1016/j.regpep.2014.12.001","url":null,"abstract":"<p><p>This article has been withdrawn at the request of the Publisher. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.</p>","PeriodicalId":20853,"journal":{"name":"Regulatory Peptides","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2014-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32890032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antimicrobial and immunomodulatory properties of PGLa-AM1, CPF-AM1, and magainin-AM1: Potent activity against oral pathogens PGLa-AM1, CPF-AM1和magainin-AM1的抗菌和免疫调节特性:对口腔病原体的有效活性
Pub Date : 2014-11-01 DOI: 10.1016/j.regpep.2014.11.002
Denise T.F. McLean , Maelíosa T.C. McCrudden , Gerard J. Linden , Christopher R. Irwin , J. Michael Conlon , Fionnuala T. Lundy

Cationic amphipathic α-helical peptides are intensively studied classes of host defence peptides (HDPs). Three peptides, peptide glycine–leucine–amide (PGLa-AM1), caerulein-precursor fragment (CPF-AM1) and magainin-AM1, originally isolated from norepinephrine-stimulated skin secretions of the African volcano frog Xenopus amieti (Pipidae), were studied for their antimicrobial and immunomodulatory activities against oral and respiratory pathogens. Minimal effective concentrations (MECs), determined by radial diffusion assay, were generally lower than minimal inhibitory concentrations (MICs) determined by microbroth dilution. PGLa-AM1 and CPF-AM1 were particularly active against Streptococcus mutans and all three peptides were effective against Fusobacterium nucleatum, whereas Enterococcus faecalis and Candida albicans proved to be relatively resistant micro-organisms. A type strain of Pseudomonas aeruginosa was shown to be more susceptible than the clinical isolate studied. PGLa-AM1 displayed the greatest propensity to bind lipopolysaccharide (LPS) from Escherichia coli, P. aeruginosa and Porphyromonas gingivalis. All three peptides showed less binding to P. gingivalis LPS than to LPS from the other species studied. Oral fibroblast viability was unaffected by 50 μM peptide treatments. Production of the pro-inflammatory cytokine IL-8 by oral fibroblasts was significantly increased following treatment with 1 or 10 μM magainin-AM1 but not following treatment with PGLa-AM1 or CPF-AM1. In conclusion, as well as possessing potent antimicrobial actions, the X. amieti peptides bound to LPS from three human pathogens and had no effect on oral fibroblast viability. CPF-AM1 and PGLa-AM1 show promise as templates for the design of novel analogues for the treatment of oral and dental diseases associated with bacteria or fungi.

阳离子两性α-螺旋肽是一类被广泛研究的宿主防御肽(hdp)。从非洲火山蛙去甲肾上腺素刺激下的皮肤分泌物中分离出甘氨酸-亮氨酸-酰胺肽(PGLa-AM1)、毛蛋白前体片段(CPF-AM1)和magainin-AM1,研究了它们对口腔和呼吸道病原体的抗菌和免疫调节活性。径向扩散法测定的最低有效浓度(MECs)通常低于微肉汤稀释法测定的最低抑制浓度(mic)。PGLa-AM1和CPF-AM1对变形链球菌特别有效,这三种肽对核梭杆菌都有效,而粪肠球菌和白色念珠菌被证明是相对耐药的微生物。一种类型的铜绿假单胞菌被证明比临床分离研究更敏感。PGLa-AM1对大肠杆菌、铜绿假单胞菌和牙龈卟啉单胞菌的脂多糖(LPS)结合能力最强。这三种肽与牙龈卟啉卟啉脂多糖的结合程度均低于与其他物种的结合程度。50 μM肽处理对口腔成纤维细胞活力无影响。1 μM magainin-AM1或10 μM magainin-AM1治疗后,口腔成纤维细胞产生的促炎细胞因子IL-8显著增加,而PGLa-AM1或CPF-AM1治疗后则没有。综上所述,除了具有有效的抗菌作用外,X. amieti肽与三种人类病原体的LPS结合,对口腔成纤维细胞的活力没有影响。CPF-AM1和PGLa-AM1有望成为设计新型类似物的模板,用于治疗与细菌或真菌相关的口腔和牙齿疾病。
{"title":"Antimicrobial and immunomodulatory properties of PGLa-AM1, CPF-AM1, and magainin-AM1: Potent activity against oral pathogens","authors":"Denise T.F. McLean ,&nbsp;Maelíosa T.C. McCrudden ,&nbsp;Gerard J. Linden ,&nbsp;Christopher R. Irwin ,&nbsp;J. Michael Conlon ,&nbsp;Fionnuala T. Lundy","doi":"10.1016/j.regpep.2014.11.002","DOIUrl":"10.1016/j.regpep.2014.11.002","url":null,"abstract":"<div><p>Cationic amphipathic α-helical peptides are intensively studied classes of host defence peptides (HDPs). Three peptides, peptide glycine–leucine–amide (PGLa-AM1), caerulein-precursor fragment (CPF-AM1) and magainin-AM1, originally isolated from norepinephrine-stimulated skin secretions of the African volcano frog <em>Xenopus amieti</em> (Pipidae), were studied for their antimicrobial and immunomodulatory activities against oral and respiratory pathogens. Minimal effective concentrations (MECs), determined by radial diffusion assay, were generally lower than minimal inhibitory concentrations (MICs) determined by microbroth dilution. PGLa-AM1 and CPF-AM1 were particularly active against <em>Streptococcus mutans</em> and all three peptides were effective against <em>Fusobacterium nucleatum</em>, whereas <em>Enterococcus faecalis</em> and <em>Candida albicans</em> proved to be relatively resistant micro-organisms. A type strain of <em>Pseudomonas aeruginosa</em> was shown to be more susceptible than the clinical isolate studied. PGLa-AM1 displayed the greatest propensity to bind lipopolysaccharide (LPS) from <em>Escherichia coli</em>, <em>P. aeruginosa</em> and <em>Porphyromonas gingivalis</em>. All three peptides showed less binding to <em>P. gingivalis</em> LPS than to LPS from the other species studied. Oral fibroblast viability was unaffected by 50<!--> <!-->μM peptide treatments. Production of the pro-inflammatory cytokine IL-8 by oral fibroblasts was significantly increased following treatment with 1 or 10<!--> <!-->μM magainin-AM1 but not following treatment with PGLa-AM1 or CPF-AM1. In conclusion, as well as possessing potent antimicrobial actions, the <em>X. amieti</em> peptides bound to LPS from three human pathogens and had no effect on oral fibroblast viability. CPF-AM1 and PGLa-AM1 show promise as templates for the design of novel analogues for the treatment of oral and dental diseases associated with bacteria or fungi.</p></div>","PeriodicalId":20853,"journal":{"name":"Regulatory Peptides","volume":"194 ","pages":"Pages 63-68"},"PeriodicalIF":0.0,"publicationDate":"2014-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.regpep.2014.11.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32857974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
期刊
Regulatory Peptides
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1